Company profile: Swift Biosciences
1.1 - Company Overview
Company description
- Provider of molecular biology reagents for research and diagnostic applications; based in Ann Arbor, Michigan.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Swift Biosciences
QurAlis
HQ: United States
Website
- Description: Provider of precision medicines for ALS and FTD, including therapeutic candidates QRL-201 to restore STMN2 expression and QRL-101 to reduce hyperexcitability-induced neurodegeneration by opening Kv7 channels, and platforms: QR43 to discover precision therapies for TDP-43-related diseases and FlexASO to develop antisense oligonucleotides that modulate RNA splicing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QurAlis company profile →
Sividon Diagnostics
HQ: Germany
Website
- Description: Provider of advanced diagnostics that facilitate therapeutic discovery, focused on improving the quality of companion diagnostics in oncology to support future cancer treatment decisions; based in Cologne, Germany, and formed via a management buyout from Siemens Healthcare Diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sividon Diagnostics company profile →
Genomic Health
HQ: United States
Website
- Description: Provider of genomic-based diagnostic tests addressing overtreatment and optimal treatment of early-stage cancer. Offers Oncotype DX Breast Recurrence Score for ER+/HER2- breast cancer, Riskguard Hereditary Cancer Test, OncoExTra genomic profiling for advanced/metastatic cancer, and developing colorectal screening (Next Generation Cologuard, blood test) and a Breast Radiation Score.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genomic Health company profile →
Epizyme
HQ: United States
Website
- Description: Provider of biopharmaceutical research and treatments focused on blood cancer and tumors. Based in Cambridge, MA and founded in 2007, the company translates epigenetic research into programs and offers Bylvay, a non-systemic ileal bile acid transport inhibitor for cholestatic pruritus in Alagille syndrome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epizyme company profile →
Nightingale Health
HQ: Finland
Website
- Description: Provider of pioneering blood-testing services and proprietary blood analysis technology that delivers deep health insights, identifies disease risks from a single sample, and measures the effects of lifestyle interventions. Offers Nightingale Pro data platform for detecting population-level disease risks and preventative health needs, and biomarker analysis services for researchers across blood, urine, and dried blood spot samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nightingale Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Swift Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Swift Biosciences
2.2 - Growth funds investing in similar companies to Swift Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Swift Biosciences
4.2 - Public trading comparable groups for Swift Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →